These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7532863)

  • 21. Enkephalinase inhibition suppresses naloxone-induced jumping in morphine-dependent mice.
    Dzoljic MR; Rademaker B; vd Poel-Heisterkamp AL; Ukponmwan OE; Haffmans J
    Arch Int Pharmacodyn Ther; 1986 Oct; 283(2):222-8. PubMed ID: 3539055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of antihistaminics on naloxone-induced withdrawal in morphine-dependent mice.
    Leza JC; Lizasoain I; Lorenzo P
    Psychopharmacology (Berl); 1990; 102(1):106-11. PubMed ID: 1975446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acutely administered clozapine does not modify naloxone-induced withdrawal jumping in morphine-dependent mice.
    Ballard TM; McAllister KH
    Pharmacol Biochem Behav; 1999 Feb; 62(2):285-90. PubMed ID: 9972695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociation of increased 5-hydroxyindoleacetic acid levels and physical dependence: the effects of naloxone.
    Laska FJ; Fennessy MR
    Clin Exp Pharmacol Physiol; 1977; 4(6):515-23. PubMed ID: 563313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of noradrenergic functions in the modification of naloxone-precipitated withdrawal jumping in morphine-dependent mice by diabetes.
    Kamei J; Ohsawa M
    Life Sci; 1997; 60(15):PL223-8. PubMed ID: 9096248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naloxone-precipitated withdrawal reveals sensitization to neurotransmitters in morphine tolerant/dependent rats.
    Schulz R; Herz A
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Aug; 299(1):95-9. PubMed ID: 20584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphine and methadone dependence in the rat: withdrawal and brain met-enkephalin levels.
    Pierce TL; Tiong GK; Olley JE
    Pharmacol Biochem Behav; 1992 May; 42(1):91-6. PubMed ID: 1528952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain serotonin turnover in morphine tolerant and dependent mice.
    Shen FH; Loh HH; Way EL
    J Pharmacol Exp Ther; 1970 Nov; 175(2):427-34. PubMed ID: 5529726
    [No Abstract]   [Full Text] [Related]  

  • 29. Chronic morphine administration decreases 5-hydroxytryptamine and 2-hydroxyindoleacetic acid content in the brain of rats.
    Ahtee L
    Med Biol; 1980 Feb; 58(1):38-44. PubMed ID: 6155571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice.
    Bhargava HN
    Psychopharmacology (Berl); 1976 Sep; 49(3):267-70. PubMed ID: 826944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circling behavior after narcotic drugs and during naloxone-precipitated abstinence in rats with unilateral nigral lesions.
    Iwamoto ET; Loh HH; Way EL
    J Pharmacol Exp Ther; 1976 Jun; 197(3):503-16. PubMed ID: 945346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Region-selective reduction of brain serotonin turnover rate and serotonin agonist-induced behavior in mice treated with clonazepam.
    Lima L
    Pharmacol Biochem Behav; 1991 Jul; 39(3):671-6. PubMed ID: 1723798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin and dopamine turnover after acute and chronic morphine administration.
    Papeschi R; Theiss P; Herz A
    Arzneimittelforschung; 1974 Jul; 24(7):1017-9. PubMed ID: 4408355
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of intragastric agmatine on morphine-induced physiological dependence in beagle dogs and rhesus monkeys.
    Su RB; Lu XQ; Huang Y; Liu Y; Gong ZH; Wei XL; Wu N; Li J
    Eur J Pharmacol; 2008 Jun; 587(1-3):155-62. PubMed ID: 18455724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of naloxone-precipitated withdrawal jumping by i.c.v. and i.t. administration of saline in morphine-dependent mice.
    Miyamoto Y; Takemori AE
    Life Sci; 1993; 52(13):1129-34. PubMed ID: 8450707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence that 5-hydroxytryptamine in the forebrain is involved in naloxone-precipitated jumping in morphine-dependent rats.
    Cervo L; Romandini S; Samanin R
    Br J Pharmacol; 1983 Aug; 79(4):993-6. PubMed ID: 6686075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.
    Schulteis G; Morse AC; Liu J
    Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physical dependence in the rat induced by slow release morphine: dose-response, time course and brain biogenic amines.
    Laska JF; Fennessy MR
    Clin Exp Pharmacol Physiol; 1976; 3(6):587-98. PubMed ID: 1034533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence of a preferential role of brain serotonin in the mechanisms leading to naloxone-precipitated compulsive jumping in morphine-dependent rats.
    Cervo L; Rochat C; Romandini S; Samanin R
    Psychopharmacology (Berl); 1981; 74(3):271-4. PubMed ID: 6791237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal.
    Higgins GA; Nguyen P; Joharchi N; Sellers EM
    Psychopharmacology (Berl); 1991; 105(3):322-8. PubMed ID: 1839177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.